These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5614163)

  • 21. [Therapeutic difficulties encountered in cases of lung tuberculosis treated with drugs].
    Wilczyński J; Paździor E
    Pneumonol Pol; 1977 Feb; 45(2):141-4. PubMed ID: 840726
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of treatment of pulmonary tuberculosis in aged patients (after 6-years of observation)].
    Smaga M; Cyganiewicz E; Mysakowska H
    Gruzlica; 1967; 35(11):1181-6. PubMed ID: 6063622
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance of the mycobacterial resistance to antitubercular agents in the therapeutic results of treatments of polyresistant patients].
    Jancik E; Novák M; Feitová S; Jan ciková M; Tousek J
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):325-8. PubMed ID: 5897860
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy of tuberculosis].
    Rev Port Pediatr Pueric; 1965 Nov; 28(11):306-14. PubMed ID: 5295697
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current incidence of primary resistance in hospitals].
    Girbal JP; Orlando JP; Taranger J; Charpin J
    Mars Med; 1972; 109(11):776-8. PubMed ID: 4662244
    [No Abstract]   [Full Text] [Related]  

  • 26. [Early results of non-effective chemotherapy with second-line drugs in pulmonary tuberculosis].
    Niemirowska H; Potworowska M
    Gruzlica; 1967 Dec; 35(12):1257-64. PubMed ID: 6079439
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical research on the use of morphazinamide in pulmonary tuberculosis].
    Jancík E
    Minerva Med; 1965 Sep; 56(71):2905-10. PubMed ID: 5322274
    [No Abstract]   [Full Text] [Related]  

  • 29. [Research on primary resistance to antitubercular agents and antibiotics in the antituberculosis centers].
    Santi GM; Poggiopollini M
    Minerva Med; 1967 Jun; 58(49):2285-8. PubMed ID: 6029301
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
    Ferraro U; Briccarello L; Vercellino E
    G Ital Mal Torace; 1968; 22(4):195-201. PubMed ID: 5743001
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary tuberculosis in a child of a parent with drug-resistant infection.
    Alexander WJ; Armstrong B; Harden JW; Housch JG
    Ala J Med Sci; 1984 Jul; 21(3):287-9. PubMed ID: 6476291
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anaphylactic shock caused by antitubercular drugs in a case of tuberculosis with primary resistance to 4 drugs].
    Rózewska M; Graczyk J
    Gruzlica; 1970 Mar; 38(3):257-60. PubMed ID: 5527050
    [No Abstract]   [Full Text] [Related]  

  • 36. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

  • 37. [Follow-up studies on patients with chronic pulmonary tuberculosis treated with secondary tuberculostatic agents].
    Böszörményi M; Faust I; Barát I; Schweiger O
    Probl Tuberk; 1965; 43(8):39-45. PubMed ID: 5869918
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined use of various secondary antitubercular agents].
    Kekkaku; 1968 Mar; 43(3):45-7. PubMed ID: 4877917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.